What’s Driving Growth in the Oral Proteins And Peptides Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the oral proteins and peptides market?
The oral proteins and peptides market has grown exponentially, expected to increase from $1.27 billion in 2024 to $1.56 billion in 2025 at a CAGR of 22.7%. Growth in past years has been fueled by the rising prevalence of chronic diseases, increased biotechnology investments, greater demand for non-invasive treatments, biopharmaceutical industry growth, and a focus on personalized medicine.
What will be the oral proteins and peptides market size in the future?
The oral proteins and peptides market is set for exponential growth, reaching $3.49 billion by 2029 at a CAGR of 22.3%. Growth is fueled by increasing demand for patient-centric drugs, an aging population, rising healthcare spending, growing diagnostic needs in cancer treatment, and a shift toward oral drug formulations. Key trends include the development of stable and efficient oral peptides, AI-driven drug discovery, advanced medical treatments, innovative drug delivery technologies, and breakthroughs in oral insulin formulations.
Get your oral proteins and peptides market report here!
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report
What main drivers are fueling expansion in the oral proteins and peptides market?
The growing biopharmaceutical industry is expected to fuel the growth of the oral proteins and peptides market. The biopharmaceutical sector focuses on drugs derived from biological sources and has seen growth due to advancements in biotechnology, increased demand for personalized medicine, and the rising prevalence of chronic diseases. Oral proteins and peptides offer non-invasive therapeutic delivery options, improving patient compliance and drug absorption. According to the European Federation of Pharmaceutical Industries and Associations, biopharmaceutical production in Europe reached $384.2 billion in 2022, marking a 4.95% increase from 2021.
What key areas define the segmentation of the global oral proteins and peptides market?
The oral proteins and peptidesmarket covered in this report is segmented –
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
Subsegments:
1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp
Who are the dominant players expanding their reach in the oral proteins and peptides market?
Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.
How are evolving market trends shaping oral proteins and peptides Strategies?
Major players in the oral proteins and peptides market are taking innovative strides, one of which is the development of Oral Semaglutide, a novel product geared towards promoting patient compliance and ease. A revolutionary medication, Oral semaglutide, is making substantial strides in the domain of oral proteins and peptides. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily injected for treating type-2 diabetes and recently used for combating obesity. In a landmark move in January 2022, India’s Novo Nordisk India rolled out the world’s inaugural oral semaglutide, signifying a monumental progression in diabetes therapy. Hitherto available only as an injectable, Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), now provides a handier oral alternative for managing type 2 diabetes. This innovation not only remolds diabetes management but also lays the foundation for future advancements in oral insulin formulations, possibly leading to more effective and patient-centric treatment options.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19629
Which regions are emerging as leaders in the oral proteins and peptides market?
North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Behavioral and Mental Health Software Global Market Report 2024
Oral Biologics & Biosimilars Global Market Report 2024
Intraoral Cameras Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intraoral-cameras-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
